his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Redox-based therapeutics in neurodegenerative disease
School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.
Instituto Teófilo Hernando for Drug Discovery, Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
University of Skövde, School of Bioscience. University of Skövde, The Systems Biology Research Centre. Redoxis AB. (Infektionsbiologi, Infection Biology)ORCID iD: 0000-0002-2812-8255
2017 (English)In: British Journal of Pharmacology, ISSN 0007-1188, E-ISSN 1476-5381, Vol. 174, no 12, 1750-1770 p.Article in journal (Refereed) Published
Abstract [en]

This review describes recent developments in the search for effective therapeutic agents that target redox homeostasis in neurodegenerative disease. The disruption to thiol redox homeostasis in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis is discussed, together with the experimental strategies that are aimed at preventing, or at least minimizing, oxidative damage in these diseases. Particular attention is given to the potential of increasing antioxidant capacity by targeting the Nrf2 pathway, the development of inhibitors of NADPH oxidases that are likely candidates for clinical use, together with strategies to reduce nitrosative stress and mitochondrial dysfunction. We describe the shortcomings of compounds that hinder their progression to the clinic and evaluate likely avenues for future research.

Place, publisher, year, edition, pages
John Wiley & Sons, 2017. Vol. 174, no 12, 1750-1770 p.
National Category
Pharmaceutical Sciences
Research subject
Infection Biology
Identifiers
URN: urn:nbn:se:his:diva-12916DOI: 10.1111/bph.13551ISI: 000402143300015PubMedID: 27477685Scopus ID: 2-s2.0-84992116486OAI: oai:DiVA.org:his-12916DiVA: diva2:968157
Available from: 2016-09-12 Created: 2016-09-12 Last updated: 2017-11-27Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Authority records BETA

Wallner, Fredrik K.

Search in DiVA

By author/editor
Wallner, Fredrik K.
By organisation
School of BioscienceThe Systems Biology Research Centre
In the same journal
British Journal of Pharmacology
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 420 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf